30 closest matches · ranked by relevance
Colorectal Neoplasms
Primary: Colorectal Cancer Screening — 127; 112 participants — p=0.01
Colorectal Cancer Screening
Primary: Facilitators and Barriers to Implementing Decision Aids, Provider Notifications, and Personal Risk Calculation Using an Electronic Health Record (EHR) to Promote…
Prostate Neoplasm
Primary: The Proportion of Men With a Positive MRI Defined by a Score of 3 or Greater — 17.7 Percentage of participants
Colorectal Cancer · Screening
Primary: Colorectal Cancer Stage (pTNM) — 46; 85 Participants
Colorectal Cancer
Primary: Colorectal Cancer Screening Participation, Defined as Completion of a Guaiac or Immunochemical Stool Occult Blood Test, Colonoscopy, Sigmoidoscopy, or Barium Enem…
Early Cancer Detection
Primary: Study Data and Samples Were Used for CancerSEEK Assay Development — 712; 3870; 5; 14 Participants
Cervical Cancer
Primary: Number of Participants Who Scheduled or Completed Cervical Cancer Screening — 28; 21 Participants
Cancer · Colorectal Cancer
Primary: Change in Correct Responses Regarding Knowledge Related to Colorectal Cancer Risk, Prevention, and Screening — -.5; 0; 1; 2 Percent Change — p=<.0001
Colorectal Cancer
Primary: FIT Completion Among Patients Offered Any Incentive vs. Outreach Alone Each Year — 2391; 738; 1255; 394 Participants — p=0.59
Colorectal Cancer
Primary: Percent of Patients Receiving GI Consult for FOBT+ Results — 39; 47; 64; 51 percent patients receiving GI consult
Colon Cancer
Primary: Assess Colorectal Cancer Screening Completion — 305; 130 Participants
Lung Cancer
Primary: Lung Cancer Deaths — 356; 443 Participants — p=0.004
Colorectal Cancer
Primary: Proportion of Subjects Who Completed Colorectal Cancer (CRC) Screening Within 6 Months (Trial - Age Group 50-75) — 598; 192 Participants
Colorectal Cancer
Primary: Number of Participants Who Completed Colorectal Cancer Screening — 11; 16; 18; 19 Participants
Lung Cancer
Primary: Number of Patients Who Received a Low Dose CT Scan of the Chest — 18 Participants
Breast, Cervical or Colorectal Cancer Screening Needed
Primary: Percentage of Participants Who Received All Needed Screening and Any Needed Screening Across the Three Randomized Arms — 57; 118; 19; 110 Participants
Colorectal Neoplasms · Digestive System Diseases · Colonic Diseases
Primary: Sensitivity and Specificity of the Exact CRC Screening Test With Comparison to Colonoscopy, Both With Respect to Cancer. — 92.3; 73.8; 93.3; 73.3 percent
Patient Compliance
Primary: Percentage of Cancer Screening Tests Completed - Intention to Treat — 10.2; 6.8; 14.7; 11.0 percentage of screening visits completed — p=<0.001
Cancer Screening Tests
Primary: Number of Participants Who Completed Colorectal Cancer Screening — 110; 95; 113; 113 Participants
Cervical Cancer
Primary: Acceptability of Self-Collection Paired With Mobile Mammography — 33 Participants
Colorectal Cancer
Primary: FIT Completion — 10.4; 13.9 Model based percentage of participants — p=.05
Colorectal Cancer
Primary: Change in Knowledge Related to Colorectal Cancer Risk, Prevention, and Screening — 1 score on a scale — p=0.0001
Cervical Cancer · Human Papillomavirus Infection
Primary: Primary Screening Participation — 144; 340; 381 Participants
Colorectal Cancer Screening · Cervical Cancer Screening
Primary: Difference in Percentage of Participants Who Completed Any Cervical PLUS Colorectal Cancer Screening Tests — 18; 1 Participants
Colorectal Cancer
Primary: Participants Completing CRC Screening Per Electronic Medical Record Documentation — 37; 59; 27 Participants
Colorectal Cancer
Primary: Intentions to Adhere to Colorectal Cancer Screening (CRCS) Recommendations — 18; 16; 21; 19 Participants
Lung Cancer
Primary: Order of LDCT — 50 Participants
Colorectal Cancer Screening
Primary: Number (and Proportion) of Participants Who Request a Colorectal Cancer (CRC) Screening Test — 16; 17; 22; 19 Participants
Colorectal Cancer
Primary: Number of Participants With CRC Screening Ordered — 162; 114 Participants — p=0.491
Colorectal Carcinoma
Primary: Likelihood of Any Colorectal Cancer (CRC) Screening (for Study-eligible Patients) — 11.8; 4.5 Percentage of participants